25CN-NBOMe

25CN-NBOMe

Error creating thumbnail:

Chemical structure of 25CN-NBOMe

25CN-NBOMe, also known as 2C-CN-NBOMe, is a synthetic psychedelic compound belonging to the NBOMe class. It is a derivative of the phenethylamine 2C-CN and is known for its potent hallucinogenic effects. The compound is primarily used in scientific research and has been studied for its interactions with the 5-HT2A receptor.

Chemical Structure and Properties

25CN-NBOMe is chemically classified as a substituted phenethylamine. Its full chemical name is 2-(4-cyanophenyl)-N-[(2-methoxyphenyl)methyl]ethanamine. The compound features a cyanide group attached to the phenyl ring, which distinguishes it from other NBOMe compounds. The presence of the methoxy group on the benzyl moiety is characteristic of the NBOMe series, contributing to its high affinity for the 5-HT2A receptor.

Pharmacology

The pharmacological effects of 25CN-NBOMe are primarily mediated through its action as a partial agonist at the 5-HT2A receptor, a subtype of the serotonin receptor. This interaction is responsible for the psychedelic effects experienced by users. The compound is known for its high potency, with active doses in the microgram range, similar to other NBOMe compounds such as 25I-NBOMe and 25C-NBOMe.

Effects

The effects of 25CN-NBOMe are similar to those of other psychedelics, including altered perception of time and space, visual hallucinations, and changes in mood and thought patterns. Due to its potency, the effects can be intense and are often unpredictable. Users have reported both positive experiences, such as enhanced creativity and introspection, and negative experiences, such as anxiety and confusion.

Legal Status

The legal status of 25CN-NBOMe varies by country. In many jurisdictions, it is classified as a controlled substance due to its potential for abuse and lack of accepted medical use. Researchers interested in studying the compound typically require special licenses to handle and experiment with it.

Safety and Toxicity

The safety profile of 25CN-NBOMe is not well-established, and there is limited data on its toxicity in humans. As with other NBOMe compounds, there is a risk of overdose, which can lead to severe adverse effects, including vasoconstriction, seizures, and serotonin syndrome. Users are advised to exercise caution and avoid combining it with other substances.

Related Pages

• NBOMe series
• Psychedelic drug
• Serotonin receptor
• 25I-NBOMe
• 25C-NBOMe